No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
323 |
4. Check minimum number of eventsNone |
323 |
5. Include endpointsNone |
323 |
6. Filter based on genotype QC (FinnGen only) |
323 |
Control definitions (FinnGen only)
- Control exclude
- E4_ENDOGLAND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E23
- Name in latin
- Diabetes insipidus
Similar endpoints
↥List of similar endpoints to
Diabetes insipidus
based on the number of shared cases.
Similar with more cases:
- Exclusions for E4_PCOS_BROAD
- Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT
- Disorders of other endocrine glands
- Used for control exclusion in common control thyroid runs
- Endocrine, nutritional and metabolic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1936 | 1022 | 905 |
| Only index persons | 1614 | 884 | 730 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 43.88 | 45.33 | 42.11 |
| Only index persons | 42.57 | 44.24 | 40.55 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 323 | 200 | 123 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.05 |
| Median age at first event (years) | 47.00 | 45.52 | 49.40 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 288
- Matched controls
- 2878
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E23.2
ICD-10 Finland
Diabetes insipidus
+∞
323.0
259
*
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
311.8
236.4
216
27
102
Kela drug reimbursment
Diabetes insipidus
+∞
224.4
185
*
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
74.2
68
*
H02AB09
ATC
hydrocortisone; systemic
84.5
73.1
80
13
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
71.9
66
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
+∞
65.1
60
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
160.5
61.7
63
5
2535A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Diabetes insipidus
+∞
37.3
35
*
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
+∞
36.2
34
*
H03AA01
ATC
levothyroxine sodium; systemic
5.1
32.4
130
400
R63.1
ICD-10 Finland
Polydipsia
+∞
30.8
29
*
25390
ICD-8 Finland
Diseases of pituitary gland, Diabetes insipidus
+∞
30.8
29
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
15.4
28.1
47
36
R35
ICD-10 Finland
Polyuria
9.2
23.2
50
64
H01AC01
ATC
somatropin; parenteral
+∞
22.2
21
*
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
56.4
18.2
21
*
N05AN01
ATC
lithium; oral
18.9
17.3
26
15
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.6
17.2
53
112
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
+∞
16.8
16
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
11.4
16.7
31
30
H53.4
ICD-10 Finland
Visual field defects
14.0
16.5
28
22
XCK00
NOMESCO Finland
Perimetry
6.7
16.2
42
71
N25.1
ICD-10 Finland
Nephrogenic diabetes insipidus
+∞
15.8
15
*
301
Kela drug reimbursment
Growth hormone
+∞
15.8
15
*
D35.30
ICD-10 Finland
Craniopharyngoma
+∞
15.8
15
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
11.0
15.3
29
29
E89.30
ICD-10 Finland
Postprocedural hypopituitarism
+∞
14.7
14
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
6.6
13.9
36
61
AA1AD
NOMESCO Finland
CT of head and brain
3.2
13.8
86
342
E23.05
ICD-10 Finland
Lack of TSH
+∞
13.6
13
*
TAB00
NOMESCO Finland
Lumbar puncture
7.2
13.6
33
51
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
+∞
12.6
12
*
E23.6
ICD-10 Finland
Other disorders of pituitary gland
+∞
11.5
11
*
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
+∞
11.5
11
*
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
+∞
11.5
11
*
E23.0
ICD-10 Finland
Hypopituitarism
+∞
11.5
11
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.2
11.5
66
242
R51.80
ICD-10 Finland
Headache
3.3
11.3
63
228
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
114.0
10.5
11
*
9350/1-C75.2
ICD-O-3
Craniopharyngioma, NOS, of craniopharyngeal duct
+∞
10.5
10
*
E23.03
ICD-10 Finland
Lack of ACTH
+∞
10.5
10
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
24.4
10.3
14
6
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
13.8
10.3
17
13
N05BA01
ATC
diazepam; systemic, rectal
3.2
9.9
55
197
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.3
9.7
51
176
N03AG01
ATC
valproic acid; systemic, rectal
4.6
9.7
33
78
N05AA02
ATC
levomepromazine; systemic
6.0
9.6
26
47
ZXC86
NOMESCO Finland
Use of endoscopic device
31.2
9.5
12
*
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
+∞
9.4
9
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.0
9.0
36
100
N91.1
ICD-10 Finland
Secondary amenorrhoea
14.6
8.8
14
10
E22.1
ICD-10 Finland
Hyperprolactinaemia
92.7
8.5
9
*
N05AH03
ATC
olanzapine; systemic
4.1
8.4
32
85
E23.3
ICD-10 Finland
Hypothalamic dysfunction, not elsewhere classified
+∞
8.4
8
*
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
+∞
8.4
8
*
2542
FHL
Transasal hypophysectomy
+∞
8.4
8
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
8.2
62
267
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
8.2
74
355
R50.9
ICD-10 Finland
Fever, unspecified
3.0
8.2
50
191
A06AD11
ATC
lactulose; oral
3.0
8.0
46
169
R42
ICD-10 Finland
Dizziness and giddiness
2.5
7.9
70
330
R60.0
ICD-10 Finland
Localized oedema
3.2
7.8
41
142
N04BC06
ATC
cabergoline; oral (dopamine agonists)
46.3
7.8
9
*
G04BD04
ATC
oxybutynin; oral, transdermal
4.7
7.7
25
57
A12BA01
ATC
potassium chloride; oral
5.6
7.5
21
40
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
82.1
7.5
8
*
N05AH04
ATC
quetiapine; oral
2.5
7.4
60
271
R33
ICD-10 Finland
Retention of urine
3.9
7.3
29
80
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
+∞
7.3
7
*
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
+∞
7.3
7
*
25310
ICD-8 Finland
Diseases of pituitary gland, Panhypopituitarismus
+∞
7.3
7
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
+∞
7.3
7
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.3
7.3
36
119
N03AX14
ATC
levetiracetam; systemic
6.3
7.2
18
30
H47.2
ICD-10 Finland
Optic atrophy
30.9
7.2
9
*
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
20.6
7.2
10
5
R53
ICD-10 Finland
Malaise and fatigue
2.4
7.0
67
327
L28
ICPC
Limited function/disability (L)
2.6
7.0
51
217
N05CD07
ATC
temazepam; oral
2.9
7.0
44
171
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
7.0
39
140
ZXC95
NOMESCO Finland
Use of surgical navigator
14.2
6.9
11
8
WX882
NOMESCO Finland
High dependency care
7.0
6.9
16
24
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
6.7
87
489
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
6.7
121
777
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.7
6.5
45
186
N05BA04
ATC
oxazepam; oral
2.1
6.5
81
448
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
7.7
6.5
14
19
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
6.4
44
180
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.5
6.4
21
49
2532A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Panhypopituitarism[PANHYPOPITUITARISMUS]
+∞
6.3
6
*
E23
ICD-10 Finland
Hypofunction and other disorders of pituitary gland
+∞
6.3
6
*
E23.06
ICD-10 Finland
Empty sella
+∞
6.3
6
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
6.5
6.2
15
24
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
6.5
6.2
15
24
UKC02
NOMESCO Finland
Cystoscopy
2.5
6.1
48
212
N06AA09
ATC
amitriptyline; systemic
2.9
6.1
35
129
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.8
6.1
16
29
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
6.0
67
350
C02AC05
ATC
moxonidine; oral
5.0
6.0
18
38
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
6.0
53
250
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.0
6.0
34
123
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
6.0
65
337
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3008295) Osmolality of Serum or Plasma
121
24
80.02
219.18
3.8
1.2
mosm/kgh2o
294.0
277.6
2.48
104
17
(3036481) Cortisol [Moles/volume] in Serum or Plasma
163
251
12.09
113.45
5.3
1.7
nmol/l
299.4
382.5
4.31
153
232
(3026782) Osmolality of Urine
165
491
5.83
55.31
4.0
2.5
mosm/kgh2o
468.9
553.3
3.59
149
421
(3035637) Corticotropin [Mass/volume] in Plasma
44
27
18.71
53.11
2.0
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
54
69
9.20
40.86
2.3
1.1
u/l
8.1
8.9
0.18
44
56
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
237
1210
4.60
34.94
10.2
6.8
mmol/l
1.2
1.2
0.57
193
1035
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
34
31
12.14
32.53
3.0
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
219
1100
4.08
31.97
10.2
6.2
mmol/l
1.2
1.2
0.33
203
1014
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
35
38
10.21
29.69
2.6
1.4
nmol/l
0.2
0.3
0.28
28
30
(3016018) Differential panel - Cerebral spinal fluid
24
16
16.12
27.36
1.8
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
38
51
8.31
27.33
1.7
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
68
164
4.99
27.24
4.3
1.9
nmol/l
13.1
13.5
0.13
62
151
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
25
22
12.23
24.30
2.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
151
752
2.89
19.32
5.4
3.4
ph
7.4
7.4
2.19
35
132
(3024980) IgG subclass 4 [Mass/volume] in Serum
28
41
7.38
18.55
1.8
1.3
g/l
0.8
0.6
0.42
20
31
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
34
62
6.01
18.32
1.6
1.2
e6/l
426.3
7.2
0.49
23
50
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
34
62
6.01
18.32
1.7
1.3
e6/l
1365.6
199.4
0.83
24
51
(3012095) Magnesium [Moles/volume] in Serum or Plasma
96
390
3.08
17.54
3.4
3.4
mmol/l
0.8
0.8
1.03
90
369
(3023323) Follitropin [Units/volume] in Serum or Plasma
47
123
4.30
16.68
2.2
1.3
iu/l
16.3
23.8
0.72
37
101
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
275
2051
3.29
13.99
8.5
3.8
pmol/l
15.1
14.6
1.75
262
1877
(3023410) Appearance of Cerebral spinal fluid
20
30
7.04
12.90
1.5
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
67
266
2.92
12.39
10.0
10.6
mmol/l
1.1
1.3
0.13
53
220
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
204
1368
2.33
11.96
5.7
5.8
umol/l
9.2
10.8
2.81
197
1298
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
20
33
6.39
11.80
1.1
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
150
912
2.20
10.83
4.2
2.9
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
12
10.35
10.50
1.2
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
167
1076
2.14
10.23
3.5
2.2
nmol/l
77.5
76.1
0.29
152
963
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
18
8.08
10.22
1.0
1.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
212
1501
2.20
10.13
8.3
4.8
mmol/l
6.6
6.6
0.07
198
1397
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
19
35
5.71
10.05
1.1
1.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
50
199
2.79
9.09
7.8
4.1
mmol/l
1.7
2.3
0.74
43
155
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
31
5.73
9.07
1.1
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
42
152
3.03
9.05
8.7
7.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
132
806
2.08
9.03
3.0
2.3
u/l
85.2
55.1
0.42
119
740
(3004789) Transferrin [Mass/volume] in Serum or Plasma
70
330
2.43
9.02
2.8
2.2
g/l
2.4
2.4
0.15
63
305
(3024139) IgG subclass 3 [Mass/volume] in Serum
16
28
5.96
8.89
1.9
1.2
g/l
0.3
0.3
—
8
18
(3027135) IgG subclass 1 [Mass/volume] in Serum
16
28
5.96
8.89
1.9
1.2
g/l
6.7
6.4
—
8
18
(4062490)
16
28
5.96
8.89
1.9
1.2
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
16
28
5.96
8.89
1.9
1.2
g/l
2.9
2.9
—
8
18
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
66
306
2.45
8.81
2.9
2.2
%
26.0
23.3
0.42
56
267
(3023368) Bacteria identified in Blood by Culture
110
633
2.12
8.76
5.3
3.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
45
175
2.83
8.52
2.6
2.9
e9/l
75.6
70.4
0.60
36
136
(3023183) Ammonium ion [Moles/volume] in Plasma
19
41
4.86
8.46
1.7
4.8
umol/l
29.0
33.4
0.47
13
33
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
14
8.10
8.03
1.3
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
136
872
1.97
7.87
8.1
5.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
115
696
2.01
7.84
3.4
2.8
e6/l
1.1
0.4
0.57
94
521
(3022948) Iron [Moles/volume] in Serum or Plasma
71
359
2.25
7.72
2.8
2.2
umol/l
14.8
13.6
0.32
66
328
(3015377) Calcium [Moles/volume] in Serum or Plasma
131
837
1.95
7.60
3.7
3.1
mmol/l
2.3
2.4
0.71
119
743
(3032080) INR in Blood by Coagulation assay
146
971
1.92
7.48
5.6
6.9
inr
1.1
1.2
0.52
43
290
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
22
6.11
7.44
1.6
1.2
nmol/l
—
—
—
0
0
(3000991) Gas panel - Venous blood
44
182
2.64
7.39
13.3
10.9
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
11
7
16.20
7.28
2.6
1.0
umol/l
2.4
5.7
—
11
7
(3005719) IgG [Mass/volume] in Serum or Plasma
48
212
2.48
7.05
2.8
2.4
g/l
10.2
10.2
0.01
40
196
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
14
27
5.37
7.03
1.6
1.2
nmol/l
—
—
—
0
0
(3009343) pH of Capillary blood
39
156
2.71
6.99
6.5
4.2
ph
7.4
7.4
—
6
16
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
8
14.18
6.94
2.3
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
110
687
1.91
6.66
3.2
2.7
—
—
—
0
0
(3019225) pH of Specimen
47
211
2.44
6.66
6.3
4.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
37
148
2.69
6.63
9.3
7.1
mmol/l
24.5
25.1
0.47
37
148
(3001604) Monocytes [#/volume] in Blood
181
1327
1.83
6.53
8.1
5.5
e9/l
0.6
0.6
1.66
159
1155
(3037467) Urinalysis macro (dipstick) panel - Urine
230
1819
1.92
6.48
6.1
4.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
142
969
1.83
6.46
2.0
1.9
pmol/l
109.3
96.2
1.54
71
503
(3006315) Basophils [#/volume] in Blood
181
1330
1.82
6.45
8.0
5.6
e9/l
0.0
0.0
0.04
159
1160
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
98
595
1.93
6.43
2.2
1.9
mg/l
2.9
3.1
0.48
89
510
(3019198) Lymphocytes [#/volume] in Blood
184
1361
1.82
6.39
8.2
5.6
e9/l
2.0
2.0
0.02
167
1208
(3002582) Erythrocytes [#/volume] in Urine
119
772
1.86
6.35
3.5
2.8
e6/l
47.6
57.8
0.14
99
599
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
71
387
2.07
6.30
2.2
1.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
251
2053
2.00
6.28
9.3
6.8
u/l
80.0
76.1
0.77
242
1919
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
26
5.17
6.28
1.5
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
104
649
1.89
6.25
4.3
3.4
%
94.5
93.7
0.13
96
637
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
27
94
3.04
6.21
1.6
2.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
36
148
2.61
6.12
6.8
4.3
mmol/l
2.3
1.9
0.24
29
114
(3013115) Eosinophils [#/volume] in Blood
185
1386
1.78
6.01
8.4
5.9
e9/l
0.2
0.2
0.21
167
1227
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
85
3.10
5.99
1.7
1.8
—
—
—
0
0
(3020891) Body temperature
25
86
3.07
5.87
9.7
4.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
133
910
1.78
5.86
4.1
3.4
e6/l
66.1
85.3
0.28
102
642
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
39
171
2.46
5.81
2.0
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
82
484
1.93
5.78
1.8
1.8
pmol/l
467.9
438.8
0.47
67
421
(3000850) Epithelial cells [#/volume] in Urine
87
528
1.89
5.62
2.6
2.3
e6/l
4.8
5.2
0.13
81
469
(3013707) Erythrocyte sedimentation rate by Westergren method
241
1978
1.86
5.53
5.2
3.9
mm/h
11.5
10.7
0.49
225
1830
(3037522) Nuclear Ab [Titer] in Serum
66
367
2.00
5.51
1.5
1.4
titre
395.0
595.9
0.84
16
88
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
282
2443
2.22
5.50
7.6
5.4
mmol/mol
39.9
39.5
0.25
268
2298
(3021960) Folate [Moles/volume] in Serum or Plasma
91
564
1.85
5.50
1.6
1.5
nmol/l
22.1
20.7
0.34
75
481
(3026008) Bacteria identified in Urine by Culture
111
732
1.79
5.47
4.3
2.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
103
666
1.80
5.41
3.5
3.1
ng/l
976.5
971.4
0.01
88
558
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
283
2468
2.18
5.22
8.2
4.5
mu/l
1.6
1.9
2.94
255
2262
(3013650) Neutrophils [#/volume] in Blood by Automated count
200
1569
1.72
5.20
11.9
8.9
e9/l
4.6
4.0
2.30
186
1375
(4027681)
10
19
5.40
5.07
1.1
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
23
4.92
5.05
1.5
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
36
4.02
5.04
3.1
2.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
54
289
2.04
4.99
2.1
2.4
umol/l
4.9
7.4
0.97
44
247
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
92
589
1.79
4.94
2.6
2.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
16
47
3.53
4.81
4.1
2.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
36
166
2.32
4.80
1.4
1.3
—
43.7
—
0
9
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
285
2516
2.13
4.70
20.8
11.3
ml/min/173m2
83.1
84.4
0.41
258
2029
(3013247) Albumin in CSF/Albumin in Serum or Plasma
7
5
14.26
4.59
1.0
1.0
mg/g
5.2
6.2
—
7
5
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
20
70
2.98
4.58
1.4
1.4
iu/ml
0.1
0.1
—
7
11
(3044640) Blood type and Crossmatch panel - Blood
114
793
1.68
4.49
2.7
2.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
175
1357
1.63
4.48
5.0
3.4
estimate
0.0
0.0
0.50
39
239
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
289
2578
2.15
4.42
5.9
4.3
mmol/l
5.9
5.9
0.04
273
2381
(3022096) Basophils/100 leukocytes in Blood
158
1201
1.62
4.34
8.2
5.6
%
0.6
0.7
0.67
148
1121
(3001122) Ferritin [Mass/volume] in Serum or Plasma
154
1164
1.62
4.33
3.5
2.6
ug/l
122.1
100.8
0.48
146
1076
(3021589) Normoblasts [#/volume] in Blood
156
1183
1.62
4.32
12.1
8.5
e9/l
0.0
0.0
0.36
131
971
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
124
889
1.64
4.31
3.8
2.9
u/l
38.2
30.5
0.55
118
854
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
6
11.88
4.29
1.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
6
11.88
4.29
1.3
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
131
954
1.63
4.27
4.8
3.4
ng/l
36.0
37.8
0.05
99
615
(3006504) Eosinophils/100 leukocytes in Blood
162
1243
1.61
4.26
8.6
5.6
%
2.6
2.8
0.36
153
1160
(4035726)
41
210
2.09
4.25
1.3
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
28
122
2.42
4.24
7.3
4.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
30
135
2.35
4.24
1.5
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
171
1334
1.60
4.16
5.1
3.3
estimate
0.0
0.0
0.00
37
244
(3021601) Nitrite [Presence] in Urine by Test strip
172
1345
1.60
4.13
6.0
4.6
estimate
0.0
0.0
0.00
38
245
(3023419) Bacteria identified in Sputum by Culture
12
32
3.86
4.12
1.9
1.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
162
1250
1.59
4.11
9.6
5.9
%
8.2
8.5
0.74
153
1175
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
33
3.74
3.96
1.1
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
164
1282
1.57
3.85
8.7
5.7
%
27.8
28.4
0.25
156
1197
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
43
233
1.98
3.83
3.9
3.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
162
1265
1.56
3.81
8.3
5.5
%
57.2
56.9
0.13
154
1187
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
5
12.19
3.77
1.2
1.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
38
198
2.04
3.77
2.8
5.2
%
0.2
0.0
0.65
12
53
(3028626) Oxygen [Partial pressure] in Capillary blood
17
61
2.89
3.75
8.5
3.7
kpa
8.9
8.1
0.91
17
56
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
85
574
1.65
3.65
1.9
1.7
mg/l
1.1
1.1
0.08
62
440
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
28
131
2.25
3.64
1.9
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
65
411
1.73
3.56
3.1
2.5
e6/l
0.7
0.9
0.47
41
227
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
17
5.41
3.53
1.4
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
17
5.41
3.53
1.0
1.2
—
—
—
0
0
(44790047)
11
31
3.64
3.51
1.4
1.7
—
—
—
0
0
(44806118)
11
31
3.64
3.51
1.4
1.7
—
—
—
0
0
(44790049)
11
31
3.64
3.51
1.4
1.7
—
—
—
0
0
(44790048)
11
31
3.64
3.51
1.4
1.7
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
6
10.16
3.51
1.3
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
6
10.16
3.51
1.3
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
34
176
2.04
3.44
5.5
2.7
e9/l
3.9
3.8
0.08
25
147
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
27
128
2.21
3.41
16.0
14.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
106
768
1.57
3.38
3.3
2.9
mmol/l
6.9
7.9
1.42
95
655
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
7
8.70
3.27
2.0
1.9
umol/l
13.9
19.9
—
6
7
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
7
8.70
3.27
1.0
1.1
—
—
—
0
0
(3036489) Thrombin time
21
91
2.40
3.25
1.9
2.2
s
21.3
20.7
0.25
16
82
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
293
2686
1.98
3.23
23.2
12.3
mg/l
19.5
21.8
0.75
248
2091
(40760892) CBC W Ordered Manual Differential panel - Blood
89
625
1.59
3.23
4.2
4.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
67
2.62
3.18
4.3
2.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
23
105
2.28
3.17
1.4
1.4
u/ml
0.8
1.3
—
7
8
(3042936) Bacteria identified in Isolate by Culture
55
343
1.73
3.15
2.0
2.2
—
—
—
0
0
(3013512) EKG study
98
708
1.55
3.13
5.2
3.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
99
717
1.55
3.13
6.5
3.7
estimate
0.0
0.0
0.50
38
243
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
135
1047
1.50
3.09
5.5
3.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
57
362
1.70
3.06
1.2
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
89
632
1.56
3.06
1.5
1.3
u/ml
3.2
1.6
0.43
22
170
(3019309) Folate [Moles/volume] in Red Blood Cells
65
428
1.65
3.05
2.0
1.6
nmol/l
1193.7
1165.5
0.10
52
325
(3014271) Vancomycin [Susceptibility]
7
12
5.94
3.03
2.3
2.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
12
5.94
3.03
1.0
1.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
39
222
1.86
3.02
3.0
4.9
%
1.6
0.7
0.66
12
69
(3021440) Promyelocytes/100 leukocytes in Blood
37
207
1.89
3.02
3.0
5.1
%
0.1
0.1
0.28
12
61
(3012516) Albumin [Mass/volume] in Urine
95
688
1.54
2.99
3.7
3.1
mg/l
29.6
250.8
0.98
68
442
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
5
10.13
2.99
1.0
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
5
10.13
2.99
1.2
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
49
301
1.74
2.96
1.7
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
36
201
1.89
2.96
2.8
4.8
%
0.4
0.3
0.12
12
50
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
13
5.48
2.88
1.6
3.4
u/ml
623.0
886.3
—
7
13
(40761536) Microorganisms panel - Urine sediment
38
218
1.84
2.88
5.3
3.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
80
565
1.55
2.80
1.5
1.4
g/l
2.1
2.3
0.79
54
353
(3021901) Oxygen saturation in Capillary blood
12
42
2.93
2.78
2.6
2.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
59
389
1.63
2.75
3.5
2.6
e6/l
3.3
2.8
0.14
32
208
(3013290) Carbon dioxide [Partial pressure] in Blood
13
48
2.78
2.75
5.1
2.3
kpa
5.0
5.1
0.12
13
48
(3027315) Oxygen [Partial pressure] in Blood
13
48
2.78
2.75
5.1
2.3
kpa
9.3
9.0
0.16
13
48
(3020682) Albumin/Creatinine [Ratio] in Urine
98
727
1.50
2.73
4.8
4.0
mg/mmol
5.4
10.6
1.39
69
455
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
19
4.29
2.69
1.6
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
30
163
1.93
2.68
2.4
3.0
ng/l
92.9
148.1
0.90
25
145
(40761535) Cells panel - Urine sediment
36
209
1.81
2.64
5.4
3.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
100
750
1.48
2.63
4.1
3.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
91
671
1.50
2.59
8.1
6.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
213
1844
1.46
2.59
4.5
2.9
u/l
44.1
44.4
0.03
200
1739
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
44
273
1.71
2.58
2.3
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
21
104
2.09
2.42
1.5
2.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
71
2.32
2.38
1.5
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
35
2.92
2.32
1.8
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
28
3.28
2.32
3.8
3.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
66
2.33
2.28
1.1
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
42
2.68
2.21
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
30
3.06
2.16
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
19
3.74
2.16
1.3
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
6
14
4.35
2.16
1.0
1.2
—
1.1
—
0
5
(3048689) Calprotectin [Mass/mass] in Stool
52
354
1.56
2.13
1.8
2.1
ug/g
127.7
109.8
0.14
37
272
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
25
3.25
2.11
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
25
3.25
2.11
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
25
3.25
2.11
1.1
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
25
3.25
2.11
1.4
2.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
31
2.96
2.09
3.4
6.4
—
4198.3
—
0
6
(21494755) Public health laboratory ask at order entry panel
16
309
0.49
2.08
1.3
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
10
5.06
2.08
1.2
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
315
1.58
2.06
4.6
4.1
%
33.7
31.1
0.63
38
216
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
268
0.46
2.04
1.5
1.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
26
3.13
2.02
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
26
3.13
2.02
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
26
3.13
2.02
1.1
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
42
276
1.60
2.00
2.5
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
47
318
1.56
1.98
2.0
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
51
2.41
1.97
2.7
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
71
2.17
1.95
1.6
1.3
ug/g
273.5
303.8
—
10
40
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
71
2.17
1.95
1.3
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
27
3.01
1.95
1.5
2.1
—
—
—
0
0
(4306422)
10
39
2.61
1.94
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
22
3.23
1.89
1.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
144
1209
1.34
1.86
4.3
3.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
62
452
1.46
1.85
4.2
3.4
ng/l
445.2
216.0
0.55
44
329
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
12
4.21
1.83
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
60
2.22
1.80
1.3
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
60
2.22
1.80
2.4
2.3
ug/min
45.7
103.8
—
7
34
(3004588) Protein electrophoresis panel - Serum or Plasma
26
155
1.74
1.79
1.9
2.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
14
68
2.11
1.73
1.1
1.3
—
73.3
—
0
9
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
13
3.89
1.72
1.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
47
0.00
1.72
0.0
1.4
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
26
2.73
1.59
21.1
20.2
nmol/l
1140.3
1585.3
—
7
26
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
26
2.73
1.59
14.1
14.1
nmol/l
519.6
847.1
—
7
26
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
183
0.48
1.56
1.3
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
93
1.87
1.54
1.4
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
15
3.37
1.53
1.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
27
2.63
1.52
1.6
2.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
58
2.11
1.51
1.3
1.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
14
74
1.93
1.41
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
53
2.11
1.40
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
43
309
1.45
1.40
1.3
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
82
658
1.33
1.39
2.6
2.7
umol/l
361.3
7117.0
3.14
67
573
(36660697) Celiac disease serology panel - Serum
34
233
1.51
1.39
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
23
2.64
1.37
1.3
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
6
23
2.64
1.37
3.3
3.7
mg/l
5.5
23.8
—
6
18
(4034850)
16
90
1.82
1.35
8.6
10.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
42
2.17
1.34
3.7
2.5
e9/l
4.6
4.5
—
9
42
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
20
121
1.70
1.34
2.2
2.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
6
24
2.53
1.31
3.5
3.0
%
45.3
62.6
—
6
15
(3045414) Leukocytes [Presence] in Urine
20
122
1.68
1.30
2.5
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
48
2.12
1.29
3.2
5.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
18
2.80
1.29
1.2
1.4
—
—
—
0
0
(4024509)
5
18
2.80
1.29
1.8
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
11
55
2.04
1.29
2.0
3.1
u/ml
0.4
0.3
—
5
28
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
44
2.07
1.28
3.7
2.9
%
61.6
55.9
—
9
44
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
44
2.07
1.28
1.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
44
2.07
1.28
1.0
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
44
2.07
1.28
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
36
2.25
1.25
1.3
1.7
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
6
25
2.43
1.25
1.5
1.4
promille
2.1
1.3
—
6
20
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
81
660
1.30
1.23
4.8
4.4
ug/l
3.0
2.2
0.28
72
594
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
71
1.87
1.21
2.0
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
26
2.33
1.19
1.2
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
88
731
1.28
1.15
1.6
1.7
mmol/l
1.5
1.4
0.31
76
628
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
65
1.88
1.15
1.5
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
28
193
1.49
1.13
1.7
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
46
350
1.37
1.11
2.1
1.9
%
1.5
1.5
0.01
40
313
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
59
1.89
1.08
1.4
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
200
1834
1.24
1.07
4.8
3.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
14
82
1.74
1.07
2.6
3.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
269
2555
1.32
1.05
4.7
3.8
mmol/l
1.4
1.3
1.74
250
2369
(21494890) Protein electrophoresis panel - 24 hour Urine
5
22
2.29
1.03
2.4
2.8
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
22
2.29
1.03
1.4
1.7
ug/l
32.0
17.0
—
5
22
(40768443) Skin Pathology biopsy report
16
99
1.65
1.02
1.2
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
48
1.90
1.01
1.1
2.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
35
2.02
1.00
1.6
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
25
174
1.47
0.98
4.3
2.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
200
1843
1.22
0.98
3.4
3.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
23
2.19
0.98
1.4
2.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
118
1032
1.23
0.97
2.3
2.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
74
617
1.26
0.94
6.2
3.4
kg/l
1.0
1.0
1.87
12
83
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
300
1.34
0.90
10.3
6.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
23
161
1.46
0.89
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
43
1.88
0.88
1.4
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
43
1.88
0.88
10.0
3.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
30
2.02
0.87
1.0
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
51
410
1.29
0.87
2.0
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
15
96
1.59
0.86
4.2
3.3
g/l
0.3
0.2
—
6
37
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
163
1.44
0.84
1.1
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
23
163
1.44
0.84
1.3
1.3
u/ml
64.7
309.8
1.01
23
148
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
324
0.72
0.79
1.9
1.8
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
27
0.00
0.78
0.0
1.0
—
1.1
—
0
10
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
27
356
0.74
0.77
1.7
2.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
24
2.10
0.75
1.0
1.7
pg
33.2
32.5
—
5
24
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
26
194
1.37
0.74
3.1
2.5
ug/l
3.4
5.5
1.30
20
173
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
13
84
1.57
0.73
1.0
1.1
—
15.8
—
0
12
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
296
2878
1.34
0.72
14.6
9.5
u/l
27.1
26.7
0.16
291
2786
(3032773) Endomysium IgG Ab [Titer] in Serum
5
26
1.94
0.71
1.2
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
275
2652
1.25
0.70
5.2
4.3
mmol/l
4.6
4.8
1.24
258
2483
(3003338) MCHC [Mass/volume]
223
2343
0.84
0.69
30.6
15.9
g/l
331.5
332.8
1.19
223
2333
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
59
1.54
0.69
2.6
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
120
0.57
0.69
1.1
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
41
333
1.26
0.66
1.4
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
28
1.80
0.66
2.8
2.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
62
1.63
0.66
1.3
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
292
2841
1.29
0.64
23.8
11.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
19
255
0.73
0.63
1.6
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
51
1.58
0.61
1.3
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
38
461
0.80
0.60
1.5
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
8
52
1.55
0.60
1.1
1.4
—
100.3
—
0
9
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
149
1.36
0.59
1.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
0.4
—
0
8
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
0.0
—
0
6
(3019230) Fractional oxyhemoglobin in Venous blood
6
35
1.73
0.58
11.8
2.4
%
75.7
61.3
—
6
35
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
35
1.73
0.58
11.2
2.3
%
12.9
13.2
—
6
35
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
273
2644
1.21
0.58
5.2
4.2
mmol/l
1.4
1.5
1.72
254
2461
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
25
194
1.31
0.58
1.1
1.2
iu/ml
98.2
147.2
—
8
87
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
203
1.31
0.58
2.0
2.8
ml/min/173m2
64.1
73.2
0.46
12
85
(3004809) Band form neutrophils/100 leukocytes in Blood
6
36
1.68
0.57
3.5
3.7
%
0.3
1.4
—
6
29
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
37
1.63
0.56
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
182
0.70
0.55
1.5
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
69
608
1.17
0.52
6.0
3.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
92
1.43
0.51
1.9
1.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
277
2699
1.18
0.46
5.7
4.7
mmol/l
2.8
2.8
0.61
259
2507
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
49
1.44
0.46
1.4
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
56
493
1.16
0.44
1.5
1.3
iu/ml
19.4
35.2
1.51
20
154
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
56
1.44
0.43
1.0
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
87
1.39
0.43
1.9
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
33
1.52
0.41
1.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
1.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
1.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
1.0
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
5.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
17
0.00
0.41
0.0
4.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
34
1.48
0.40
1.0
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
34
1.48
0.40
1.0
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
34
1.48
0.40
1.2
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
12
90
1.35
0.36
1.0
1.4
miu/ml
164.9
281.8
—
6
47
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
78
0.64
0.36
1.0
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
42
1.44
0.35
1.2
1.7
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
7
53
1.33
0.31
3.3
3.2
mmol/l
8.2
7.5
—
7
53
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
53
1.33
0.31
1.1
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
57
1.23
0.29
2.1
1.8
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
7
57
1.23
0.29
3.3
3.1
mmol/l
1.5
1.5
—
7
57
(3000330) Specific gravity of Urine by Test strip
15
123
1.23
0.26
3.7
3.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
94
996
0.92
0.25
3.8
2.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
39
1.29
0.23
1.2
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
88
1.26
0.23
1.4
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
124
0.80
0.22
1.4
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
90
1.23
0.19
1.4
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
52
1.16
0.19
1.0
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
59
1.19
0.18
1.1
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
91
1.22
0.18
1.4
1.2
—
—
—
0
0
(1002224) Polysomnography panel
11
131
0.83
0.17
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
70
1.15
0.16
2.3
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
49
523
0.93
0.16
3.9
4.1
%
23.2
21.3
0.34
18
235
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
35
379
0.91
0.16
3.5
2.7
ug/l
1.2
0.8
0.34
29
233
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
119
0.84
0.15
1.6
1.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
83
1.09
0.15
1.6
1.6
—
—
—
0
0
(4010399)
20
181
1.11
0.12
1.9
1.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
303
3012
1.10
0.10
36.4
18.1
pg
30.2
30.3
0.30
303
2974
(3024731) MCV [Entitic volume]
303
3012
1.10
0.10
36.5
18.2
fl
90.9
90.8
0.24
303
2974
(3000492) Spirometry study
29
272
1.07
0.09
1.6
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
55
1.09
0.09
1.3
1.9
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
303
3014
1.09
0.08
36.8
18.4
g/l
134.7
136.5
1.61
303
2974
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
88
1.14
0.08
1.6
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
66
1.06
0.08
5.6
4.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
50
482
1.04
0.07
1.5
1.3
u/ml
4.3
11.6
1.28
22
202
(46235355) HIV 1 and 2 tests - Meaningful Use set
51
492
1.04
0.07
2.2
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
87
1.04
0.07
1.2
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
93
0.86
0.07
1.3
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
251
2492
1.03
0.06
24.7
13.3
%
39.1
40.3
0.97
163
1902
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
25
263
0.95
0.05
3.2
4.0
ug/l
3.7
48.3
0.86
19
219
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
159
1.07
0.05
1.3
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
180
1.06
0.04
1.6
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
149
0.94
0.03
1.5
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
54
530
1.02
0.02
1.5
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
30
292
1.03
0.02
1.3
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
116
0.95
0.00
1.1
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
129
1.01
0.00
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
123
0.97
0.00
1.3
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
95
1.05
0.00
1.3
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
74
743
0.99
0.00
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
28
285
0.98
0.00
1.3
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
30
295
1.02
0.00
1.2
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
124
0.97
0.00
1.3
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
124
0.97
0.00
1.3
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
14
136
1.03
0.00
3.6
2.5
e6/l
0.4
0.1
0.54
14
131
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.9
—
0
5
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
8
0.00
0.00
0.0
5.1
—
48.1
—
0
8
(3044007) Cell count panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
89
0.90
0.00
2.0
2.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(4015189)
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
9.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
96
0.94
0.00
1.1
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
8
0.00
0.00
0.0
5.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_DIABINSIPIDUS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_DIABINSIPIDUS | 3.239 [2.46, 4.27] | < 0.001 |
| Birth year | 1.001 [0.99, 1.01] | 0.864 |
During the follow-up period (1.1.1998 — 31.12.2019), 127 out of 716 females with E4_DIABINSIPIDUS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_DIABINSIPIDUS | 2.412 [1.78, 3.27] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 120 out of 595 males with E4_DIABINSIPIDUS died.
Mortality risk
Mortality risk for people of age
years, who have E4_DIABINSIPIDUS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.39% | 0.489% |
| 5 | 2.107% | 3.104% |
| 10 | 5.629% | 7.422% |
| 15 | 10.58% | 13.857% |
| 20 | 18.654% | 22.663% |
Relationships between endpoints
↥Index endpoint: E4_DIABINSIPIDUS – Diabetes insipidus
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data